Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9875356 | 0.84 | AHR (0.40) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL316417 | 0.77 | AHR (0.50) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL31085202 | 0.77 | AHR (0.50) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL25116194 | 0.76 | — | — | |
| SCHEMBL21399749 | 0.76 | MMP12 (0.33) | MAPTHTT | |
| SCHEMBL10687923 | 0.76 | MAPT (0.38) | MAPT | |
| SCHEMBL3545157 | 0.70 | AHR (0.31) | AHR | |
| SCHEMBL9349990 | 0.69 | AHR (0.42) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL12046 | 0.68 | AHR (0.50) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL31466520 | 0.67 | LMNA (0.40) | AHRLMNAMAPTHTTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4298103-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | Enanta Pharmaceuticals, Inc. (US) | 2024-01-03 | — | — | EP | disclosed |
| CN-117043166-A | Antiviral heterocyclic compounds | 英安塔制药有限公司 | 2023-11-10 | — | — | CN | disclosed |
| WO-2023200441-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ENANTA PHARMACEUTICALS, INC. (US) | 2023-10-19 | — | — | WO | disclosed |
| WO-2022182861-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ENANTA PHARMACEUTICALS, INC. (US) | 2022-09-01 | — | — | WO | disclosed |